Global burden of irritable bowel syndrome: trends, predictions and risk factors

Irritable bowel syndrome (IBS) is one of the most common disorders of gut–brain interaction worldwide, defined according to patterns of gastrointestinal symptoms as described by the Rome diagnostic criteria. However, these criteria, developed with reference to research conducted largely in Western populations, might be limited in their applicability to other countries and cultures. Epidemiological data show a wide variation in the prevalence of IBS globally and more rigorous studies are needed to accurately determine any differences that might exist between countries as well as the potential explanations. The effects of IBS on the individual, in terms of their quality of life, and on health-care delivery and society, in terms of economic costs, are considerable. Although the magnitude of these effects seems to be comparable between nations, their precise nature can vary based on the existence of societal and cultural differences. The pathophysiology of IBS is complex and incompletely understood; genetics, diet and the gut microbiome are all recognized risk factors, but the part they play might be influenced by geography and culture, and hence their relative importance might vary between countries. This Review aims to provide an overview of the burden of IBS in a global context, to discuss future implications for the care of people with IBS worldwide, and to identify key areas for further research. Irritable bowel syndrome is one of the most common gut disorders worldwide and is defined according to patterns of gastrointestinal symptoms that might be limited in their applicability to all countries and cultures. This Review provides an overview of the global burden of irritable bowel syndrome and discusses the implications for the care of patients worldwide.